|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






IM/Ambulatory care 





Geriatrics 





Rheumatology 





Key Words: fractures calcium bone density osteoporosis (postmenopausal)
| The first 150 words of the full text of this article appear below. |
METHODS
Data sources:
Cochrane Controlled Trials Register (2001), Medline (January 1966 to April 2001), EMBASE/Excerpta Medica (January 1966 to April 2001), Current Contents (review of the 6 mo prior to April 2001), bibliographies of relevant articles, experts, and proceedings of international meetings.
Study selection and assessment:
randomised controlled trials (RCTs) that compared calcium supplementation (
400 mg/d) with usual calcium intake where both groups received a maintenance dose of vitamin D
400 IU/day and a vitamin D loading dose
300 000 IU; examined women >45 years who were postmenopausal (absence of menses of
6 mo); reported fractures or BMD of the total body, vertebral spine, hip, or forearm; and had follow up for
1 year. 3 independent reviewers assessed methodological quality including allocation concealment, blinding, and losses to follow up.
Outcomes:
BMD and fractures.
MAIN RESULTS
15 studies (1806 participants, 953 of whom received calcium supplementation) met the selection criteria. 13 studies reported
Steven Cummings, MD, FACP1, Deborah Sellmeyer, MD2
1 California Pacific Medical Center Research Institute
2 University of California, San Francisco
San Francisco, California, USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |